30起交易近138亿美元!默沙东达成100亿美元大额并购;艾伯维超19亿美元引进三抗管线 | 一周交易

创鉴汇
Jul 17, 2025

据创鉴汇不完全统计,7月7日至7月13日全球生物制药领域共披露30起交易事件,潜在交易总额近138亿美元。上周最重磅的交易当属默沙东(MSD)以100亿美元收购Verona Pharma,这也是2025年迄今创新药领域第二大并购。通过此次收购,默沙东将获得Ohtuvayre(ensifentrine),这是一款PDE3和PDE4双重抑制剂,于2024年6月获美国FDA批准用于治疗成年患者慢性阻塞性...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10